Combination of the pro-apoptotic TRAIL-receptor antibody mapatumumab with ionizing radiation strongly increases long-term tumor control under ambient and hypoxic conditions.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples